← Leaderboards
Ted S Strom
University Of Tennessee Health Sci Ctr
$878,425
Attributed
$878,425
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $182.5K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$878,425 · 2
By mechanism
K08$540,000 · 1
R21$338,425 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Yi Zheng$32,153,231
- Bernd Meibohm$2,938,789
Others in their field
Top investigators on “Thrombocytopenia”
- Thomas L Ortel · Duke University$23,613,789
- Mortimer Poncz · University Of Pennsylvania$19,917,641
- Joseph E Italiano · Brigham And Women'S Hospital$12,297,098
- Douglas Brock Cines · Duke University$11,304,101
- Gregory William Henkel · Arisan Therapeutics, Inc.$10,706,799
- Karin Maria Hoffmeister · Versiti Blood Health, Inc.$10,379,020
Research focus
ThrombocytopeniaBlood PlateletsHematopoieticBone Marrow PurgingEczemaPlatelet Count MeasurementResponseGene TherapyIn VivoRelative (Related Person)ProductionT-LymphocyteWiskott-Aldrich SyndromeImmunologic Deficiency SyndromesConsumptionDesignTherapy Design /DevelopmentWiskott Aldrich SyndromeLaboratory MouseDisease /Disorder ModelBaseAutoimmunityAntibodiesAutoimmune Responses
Grant awards (8)
Determination of a Mechanism for the Thrombocytopenia of WAS$155,925
R21 · FY2010 · AI · contact PI
Determination of a Mechanism for the Thrombocytopenia of WAS$182,500
R21 · FY2009 · AI · contact PI
Gene Therapy for the Wiskott Aldrich Syndrome$108,000
K08 · FY2008 · HL · contact PI
Gene Therapy for the Wiskott Aldrich Syndrome$108,000
K08 · FY2007 · HL · contact PI
Gene Therapy for the Wiskott Aldrich Syndrome$108,000
K08 · FY2006 · HL · contact PI
Gene Therapy for the Wiskott Aldrich Syndrome$108,000
K08 · FY2005 · HL
Gene Therapy for the Wiskott Aldrich Syndrome$107,999
K08 · FY2004 · HL
Gene Therapy for the Wiskott Aldrich Syndrome$1
K08 · FY2004 · HL